Abiomed
ABMD
#1257
Rank
A$25.86 B
Marketcap
A$573.63
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : A$0.23 Billion

According to Abiomed's latest financial reports the company's total liabilities are A$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31A$0.22 B4.68%
2021-03-31A$0.21 B-11.86%
2020-03-31A$0.24 B49.02%
2019-03-31A$0.16 B30.98%
2018-03-31A$0.12 B-1.99%
2017-03-31A$0.12 B78.85%
2016-03-31A$71.91 M16.98%
2015-03-31A$61.47 M53.78%
2014-03-31A$39.97 M26.45%
2013-03-31A$31.61 M18.85%
2012-03-31A$26.6 M2.4%
2011-03-31A$25.97 M10.65%
2010-03-31A$23.47 M-17.84%
2009-03-31A$28.57 M7.71%
2008-03-31A$26.53 M52.16%
2007-03-31A$17.43 M36.01%
2006-03-31A$12.82 M102.93%
2005-03-31A$6.31 M-1.35%
2004-03-31A$6.4 M-38.16%
2003-03-31A$10.35 M-45.83%
2002-03-31A$19.11 M-1.03%
2001-03-31A$19.31 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
A$6.09 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$28.72 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
A$0.23 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA